Cargando…

Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline

Off-label drugs use is widespread in ophthalmology due to the delay in drug approvals and package inserts update. It has been found to vary among different medical institutions in China, leading to safety problems since inappropriate use. Guidance is urgently needed regarding how best to use the dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Guangyao, Wang, Ningli, Zhang, Yu, Wei, Wenbin, Lu, Hai, Zhai, Suodi, Zhang, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171102/ https://www.ncbi.nlm.nih.gov/pubmed/35685634 http://dx.doi.org/10.3389/fphar.2022.919688

Ejemplares similares

Recommendations on Off-Label Drug Use in Pediatric Guidelines
por: Meng, Min, et al.
Publicado: (2022)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
por: WANG, Weilan, et al.
Publicado: (2013)

Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis
por: Wei, Guoxu, et al.
Publicado: (2021)

Management of Ventilator-Associated Pneumonia: Quality Assessment of Clinical Practice Guidelines and Variations in Recommendations on Drug Therapy for Prevention and Treatment
por: Li, Hong-Yan, et al.
Publicado: (2022)

Bevacizumab: Off-label use in ophthalmology
por: Grisanti, Salvatore, et al.
Publicado: (2007)

Guideline for the management of pediatric off-label use of drugs in China (2021)
por: Meng, Min, et al.
Publicado: (2022)

Off-label drug prescriptions in French general practice: a cross-sectional study
por: Drogou, François, et al.
Publicado: (2019)

Individualized Medication of Voriconazole: A Practice Guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society
por: Chen, Ken, et al.
Publicado: (2018)

Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review
por: Fischler, Pascal Valentin, et al.
Publicado: (2022)

Utilisation of drugs for the treatment of psychiatric diseases in the pediatric population: focus on off-label use
por: Pesiou, Stella, et al.
Publicado: (2023)

The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China
por: Zhou, Pengxiang, et al.
Publicado: (2022)

Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization
por: Zhang, Yahui, et al.
Publicado: (2021)

A Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)
por: Li, Xiaotong, et al.
Publicado: (2022)

Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab
por: Zhang, Zhiyu, et al.
Publicado: (2023)

Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis
por: Zhou, Pengxiang, et al.
Publicado: (2021)

α1-Blockers and 5α-Reductase Inhibitors Are the Most Recommended Drugs in Treating Benign Prostatic Hyperplasia: An Evidence-Based Evaluation of Clinical Practice Guidelines
por: Xu, Xiao-Feng, et al.
Publicado: (2020)

Development of the First Value Assessment Index System for Off-Label Use of Antineoplastic Agents in China: A Delphi Study
por: Jiang, Qian, et al.
Publicado: (2020)

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
por: Verbaanderd, Ciska, et al.
Publicado: (2020)

Predicting the Outcome of Voriconazole Individualized Medication Using Integrated Pharmacokinetic/Pharmacodynamic Model
por: Yang, Ping, et al.
Publicado: (2021)

Evaluation of the clinical practice guidelines and consensuses on calcium and vitamin D supplementation in healthy children using the Appraisal of Guidelines for Research and Evaluation II instrument and Reporting Items for Practice Guidelines in Healthcare statement
por: He, Lanzhi, et al.
Publicado: (2022)

The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion
por: van Tongeren, Justine M. Z., et al.
Publicado: (2020)

Judicial and legislative practice and related suggestions on off-label drug use in China
por: Si, Wenjie, et al.
Publicado: (2023)

Clinical practice guidelines for translating pharmacogenomic knowledge to bedside. Focus on anticancer drugs
por: Agúndez, José A. G., et al.
Publicado: (2014)

Prescription Pattern and Off-Label Use of Antipsychotics in a Middle Eastern Population
por: Bastaki, Kholoud, et al.
Publicado: (2021)

Drug Prescriptions in the Outpatient Management of COVID-19: Evidence-Based Recommendations Versus Real Practice
por: Belleudi, Valeria, et al.
Publicado: (2022)

Pediatric ophthalmology, strabismus and neuro-ophthalmology practice in the COVID-19 era: All India Ophthalmological Society guidelines
por: Saxena, Rohit, et al.
Publicado: (2020)

A Review of CYP3A Drug-Drug Interaction Studies: Practical Guidelines for Patients Using Targeted Oral Anticancer Drugs
por: Molenaar-Kuijsten, Laura, et al.
Publicado: (2021)

Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis
por: Shen, Nan-Nan, et al.
Publicado: (2021)

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines
por: Manson, Lisanne E. N., et al.
Publicado: (2020)

Label-free drug discovery
por: Fang, Ye
Publicado: (2014)

COVID-19: Preliminary Clinical Guidelines for Ophthalmology Practices
por: Gharebaghi, Reza, et al.
Publicado: (2020)

Prognostic Value of Pericardial Effusion Size in Patients with Acute Heart Failure
por: Zhai, Guangyao, et al.
Publicado: (2022)

Factors Associated With Off-Label Oncology Prescriptions: The Role of Cost and Financing in a Universal Healthcare System
por: Gordon, Noa, et al.
Publicado: (2021)

Current practice and awareness of pediatric off-label drug use in Shanghai, China -a questionnaire-based study
por: Mei, Mei, et al.
Publicado: (2019)

Clarity and applicability of adverse drug reaction-related monitoring instructions in clinical practice guidelines for children and adolescents treated with antipsychotic drugs: a review of six clinical practice guidelines
por: Minjon, Lenneke, et al.
Publicado: (2022)

The Off-Label Use of Antineoplastics in Oncology Is Limited But Has Notable Scientific Support in a University Hospital Setting
por: Herrero Fernandez, Marta, et al.
Publicado: (2019)

The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
por: Tesar, Tomas, et al.
Publicado: (2021)

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
por: Vitale, Antonio, et al.
Publicado: (2016)

Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database
por: Gozzo, Lucia, et al.
Publicado: (2021)

Anxiety, Loneliness, Drug Craving, and Depression Among Substance Abusers in Sichuan Province, China
por: Chen, Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fv739mr3loms27jjq764g1274l